Last updated: 12 August 2024 at 5:00pm EST

Kenneth Mills Net Worth




The estimated Net Worth of Kenneth T. Mills is at least $24.5 Million dollars as of 8 August 2024. Mr. Mills owns over 36,316 units of Regenxbio Inc stock worth over $5,647,701 and over the last 9 years he sold RGNX stock worth over $12,738,759. In addition, he makes $6,147,270 as President, Chief Executive Officer, and Executive Director at Regenxbio Inc.

Mr. Mills RGNX stock SEC Form 4 insiders trading

Kenneth has made over 58 trades of the Regenxbio Inc stock since 2016, according to the Form 4 filled with the SEC. Most recently he exercised 36,316 units of RGNX stock worth $30,869 on 8 August 2024.

The largest trade he's ever made was exercising 150,000 units of Regenxbio Inc stock on 11 January 2018 worth over $127,500. On average, Kenneth trades about 19,309 units every 43 days since 2015. As of 8 August 2024 he still owns at least 444,351 units of Regenxbio Inc stock.

You can see the complete history of Mr. Mills stock trades at the bottom of the page.





Kenneth Mills biography

Kenneth T. Mills serves as President, Chief Executive Officer, Executive Director of the Company. He has been our President, Chief Executive Officer and Director since March 2009. Mr. Mills was with FOXKISER, most recently as a Partner, from January 2007 to January 2015. Mr. Mills was previously the Chief Financial Officer and Vice President of Business Development at Meso Scale Diagnostics, a life sciences company, from January 2004 to December 2006 and was part of the original management team that established the company’s operations and financing strategy. From March 1997 to December 2003, Mr. Mills was employed at IGEN, a biotechnology company, where he served as Director of Business Development up through the company’s acquisition by Roche. Mr. Mills received an S.B. in Chemistry from the Massachusetts Institute of Technology. Mr. Mills’ qualifications to continue to serve as a member of the Board include his extensive experience as an executive in the gene therapy and biotechnology industries, including as President and Chief Executive Officer of our Company, his prior service as a senior-level executive in both early stage and mature biotechnology companies and his demonstrated business judgment.

What is the salary of Kenneth Mills?

As the President, Chief Executive Officer, and Executive Director of Regenxbio Inc, the total compensation of Kenneth Mills at Regenxbio Inc is $6,147,270. There are no executives at Regenxbio Inc getting paid more.



How old is Kenneth Mills?

Kenneth Mills is 45, he's been the President, Chief Executive Officer, and Executive Director of Regenxbio Inc since 2009. There are 19 older and no younger executives at Regenxbio Inc. The oldest executive at Regenxbio Inc is Allan Fox, 72, who is the Chairman of the Board.

What's Kenneth Mills's mailing address?

Kenneth's mailing address filed with the SEC is C/O REGENXBIO INC., 9804 MEDICAL CENTER DRIVE, ROCKVILLE, MD, 20850.

Insiders trading at Regenxbio Inc

Over the last 9 years, insiders at Regenxbio Inc have traded over $44,148,392 worth of Regenxbio Inc stock and bought 175,000 units worth $3,850,000 . The most active insiders traders include Llc Fmr, Argeris N Karabelas, and Edgar Engleman. On average, Regenxbio Inc executives and independent directors trade stock every 15 days with the average trade being worth of $238,185. The most recent stock trade was executed by Argeris N Karabelas on 3 September 2024, trading 10,000 units of RGNX stock currently worth $37,600.



What does Regenxbio Inc do?

regenxbio is a leading biotechnology company focused on the development, commercialization and licensing of recombinant adeno‐associated virus (aav) gene therapy. regenxbio's nav® technology platform, a proprietary aav gene delivery platform, consists of exclusive rights to more than 100 novel aav vectors, including aav7, aav8, aav9 and aavrh10. regenxbio's mission is to transform the lives of patients suffering from severe diseases with significant unmet medical need by developing and commercializing in vivo gene therapy products based on regenxbio's nav technology platform. regenxbio seeks to accomplish this mission through a combination of internal development efforts and third‐party nav technology platform licensees.



What does Regenxbio Inc's logo look like?

Regenxbio Inc logo

Complete history of Mr. Mills stock trades at Regenxbio Inc

Date
#
Company
Insider
Trans.
Transaction
Shares Price per share Total value Shares after Source
8 Aug 2024 Kenneth T. Mills
Option 36,316 $0.85 $30,869
8 Aug 2024
444,351
24 Jul 2024 Kenneth T. Mills
Option 27,590 $3.76 $103,738
24 Jul 2024
423,404
16 Jul 2024 Kenneth T. Mills
Option 2,410 $3.76 $9,062
16 Jul 2024
410,245
14 May 2024 Kenneth T. Mills
Option 15,000 $3.76 $56,400
14 May 2024
423,035
15 Apr 2024 Kenneth T. Mills
Option 15,000 $3.76 $56,400
15 Apr 2024
423,035
14 Mar 2024 Kenneth T. Mills
Option 15,000 $3.76 $56,400
14 Mar 2024
423,035
14 Feb 2024 Kenneth T. Mills
Option 15,000 $3.76 $56,400
14 Feb 2024
423,035
16 Jan 2024 Kenneth T. Mills
Option 45,000 $3.76 $169,200
16 Jan 2024
453,035
19 Dec 2023 Kenneth T. Mills
Option 45,000 $3.66 $164,700
19 Dec 2023
400,289
8 Nov 2021 Kenneth T. Mills
Option 1,500 $3.76 $5,640
8 Nov 2021
282,484
27 Sep 2021 Kenneth T. Mills
Option 1,500 $3.76 $5,640
27 Sep 2021
282,484
13 Sep 2021 Kenneth T. Mills
Option 38,000 $3.62 $137,560
13 Sep 2021
315,984
24 Jun 2021 Kenneth T. Mills
Option 6,000 $3.76 $22,560
24 Jun 2021
282,484
25 Feb 2021 Kenneth T. Mills
Option 1,500 $0.85 $1,275
25 Feb 2021
282,484
25 Jan 2021 Kenneth T. Mills
Option 6,500 $0.85 $5,525
25 Jan 2021
287,484
7 Jan 2021 Kenneth T. Mills
Option 1,500 $0.85 $1,275
7 Jan 2021
283,484
28 Dec 2020 Kenneth T. Mills
Option 6,500 $0.85 $5,525
28 Dec 2020
247,500
23 Dec 2020 Kenneth T. Mills
Option 4,500 $0.85 $3,825
23 Dec 2020
245,500
16 Dec 2020 Kenneth T. Mills
Option 15,000 $0.85 $12,750
16 Dec 2020
256,000
10 Dec 2020 Kenneth T. Mills
Option 4,500 $0.85 $3,825
10 Dec 2020
245,500
19 Sep 2019 Kenneth T. Mills
Sale 10,000 $39.75 $397,500
19 Sep 2019
241,000
19 Aug 2019 Kenneth T. Mills
Option 15,000 $0.85 $12,750
19 Aug 2019
261,000
19 Jul 2019 Kenneth T. Mills
Option 15,000 $0.85 $12,750
19 Jul 2019
261,000
19 Jun 2019 Kenneth T. Mills
Option 15,000 $0.85 $12,750
19 Jun 2019
261,000
20 May 2019 Kenneth T. Mills
Option 15,000 $0.85 $12,750
20 May 2019
261,000
22 Apr 2019 Kenneth T. Mills
Option 15,000 $0.85 $12,750
22 Apr 2019
261,000
19 Mar 2019 Kenneth T. Mills
Option 15,000 $0.85 $12,750
19 Mar 2019
261,000
14 Feb 2019 Kenneth T. Mills
Option 15,000 $0.85 $12,750
14 Feb 2019
261,000
1 Feb 2019 Kenneth T. Mills
Option 45,000 $0.85 $38,250
1 Feb 2019
246,000
15 Jan 2019 Kenneth T. Mills
Sale 15,000 $43.85 $657,750
15 Jan 2019
201,000
17 Dec 2018 Kenneth T. Mills
Sale 15,000 $46.73 $700,950
17 Dec 2018
216,000
3 Dec 2018 Kenneth T. Mills
Sale 20,000 $60.40 $1,208,000
3 Dec 2018
231,000
26 Nov 2018 Kenneth T. Mills
Sale 20,000 $64.17 $1,283,400
26 Nov 2018
251,000
21 Nov 2018 Kenneth T. Mills
Sale 15,000 $61.44 $921,600
21 Nov 2018
271,000
12 Nov 2018 Kenneth T. Mills
Sale 20,000 $63.11 $1,262,200
12 Nov 2018
286,000
5 Nov 2018 Kenneth T. Mills
Sale 20,000 $68.25 $1,365,000
5 Nov 2018
306,000
15 Oct 2018 Kenneth T. Mills
Sale 7,510 $59.35 $445,719
15 Oct 2018
326,000
17 Sep 2018 Kenneth T. Mills
Sale 7,510 $74.91 $562,574
17 Sep 2018
333,510
27 Aug 2018 Kenneth T. Mills
Option 145,000 $0.85 $123,250
27 Aug 2018
348,530
20 Jun 2018 Kenneth T. Mills
Sale 5,000 $66.20 $331,000
20 Jun 2018
203,530
21 May 2018 Kenneth T. Mills
Sale 10,000 $47.05 $470,500
21 May 2018
208,530
20 Apr 2018 Kenneth T. Mills
Sale 10,000 $39.52 $395,200
20 Apr 2018
218,530
20 Mar 2018 Kenneth T. Mills
Sale 10,000 $29.55 $295,500
20 Mar 2018
228,530
20 Feb 2018 Kenneth T. Mills
Sale 10,000 $26.56 $265,600
20 Feb 2018
238,530
22 Jan 2018 Kenneth T. Mills
Sale 10,000 $27.33 $273,300
22 Jan 2018
248,530
11 Jan 2018 Kenneth T. Mills
Option 150,000 $0.85 $127,500
11 Jan 2018
258,530
20 Dec 2017 Kenneth T. Mills
Sale 10,000 $31.75 $317,500
20 Dec 2017
108,530
20 Nov 2017 Kenneth T. Mills
Option 30,000 $0.85 $25,500
20 Nov 2017
128,530
20 Oct 2017 Kenneth T. Mills
Sale 10,000 $32.62 $326,200
20 Oct 2017
98,530
20 Sep 2017 Kenneth T. Mills
Sale 10,000 $29.33 $293,300
20 Sep 2017
108,530
5 Sep 2017 Kenneth T. Mills
Sale 10,500 $25.00 $262,500
5 Sep 2017
118,530
25 Aug 2017 Kenneth T. Mills
Option 23,530 $0.85 $20,001
25 Aug 2017
129,030
21 Aug 2017 Kenneth T. Mills
Sale 6,500 $20.05 $130,325
21 Aug 2017
105,500
20 Jul 2017 Kenneth T. Mills
Sale 6,500 $18.66 $121,290
20 Jul 2017
112,000
20 Jun 2017 Kenneth T. Mills
Sale 6,500 $19.68 $127,920
20 Jun 2017
118,500
24 Apr 2017 Kenneth T. Mills
Sale 15,440 $20.98 $323,931
24 Apr 2017
125,000
13 Jun 2016 Kenneth T. Mills
Option 125,000 $0.85 $106,250
13 Jun 2016
140,440
13 Jun 2016 Kenneth T. Mills
Option 125,000 $0.85 $106,250
13 Jun 2016
140,440


Regenxbio Inc executives and stock owners

Regenxbio Inc executives and other stock owners filed with the SEC include: